Abstract:Objective:To explore the efficacy and safety of patent ductus arteriosus (PDA) ligation in extremely premature infants.Methods:Clinical data were retrospectively reviewed for 49 extremely preterm PDA infants admitted into Neonatal Intensive Care Unit of Children's Hospital, Zhejiang University School of Medicine. They underwent surgical intervention at Department of Cardiac Surgery from January 2015 to December 2019. There were 27 boys and 22 girls with a gestational age < 28 weeks, an average gestational age of 26 +5 weeks and a gestational age range of 24 +5 to 27 +6 weeks; multiple pregnancies accounted for 38.8% (19/49) ; birth weight was (930±148) g; diameter of PDA assessed by preoperative ultrasound was (4.0±0.8) mm; there were approximately 1.6 courses of drug treatment. Basic clinical data, early surgical prognosis, inhospital mortality and operation-related complications were recorded. Durations of ventilator support and oxygen therapy before and after operation were compared. And clinical characteristics and therapeutic effect of PDA ligation were summarized. Results:Operative duration was (52±16) min, average operative age 42.4 days, average operative weight 1.68 kg, median diameter of PDA 3.8 mm, average corrected age at discharge 42 +6 weeks and average weight at discharge 3.47 kg. Without mortality, none had residual fistula postoperatively and achieved immediate closure. Two children had left vocal cord paralysis preoperatively. No new case of nerve injury occurred postoperatively. Postoperative pneumothorax accounted for 10.2% (5/49) . Four pre-discharge deaths were not related with surgery and there was an in-hospital mortality rate of 8.2 % (4/49 ) . Preoperative invasive mechanical ventilation support accounted for 85.7% (42/49) and non-invasive positive pressure ventilation support 14.3% (7/49) . Total mechanical ventilation time during hospitalization was (42±37) days and total ventilator support time of invasive mechanical ventilation and non-invasive positive pressure ventilation was (73±34) days. The differences between pre and post-operation of invasive mechanical ventilation time and total ventilator support time were (12.4±26.5) and (32.2±35.0) days ( P=0.003, P<0.001) and the differences were statistically significant. Survival analysis revealed that infants with multiple pregnancies, operative weight ≥1.5 kg and PDA diameter < 3.8 mm could be weaned off ventilator treatment and oxygen therapy earlier postoperatively. Conclusions:Surgical ligation is both safe and effective for PDA in extremely premature infants.

Catheter closure of patent ductus arteriosus by mushroom shape occluder in infants

Clinical evaluation of catheter closure of patent ductus arteriosus by Chinese-made mushroom-shape occluder in adults

Catheter closure of patent ductus arteriosus with pulmonary hypertension by domestic-made mushroom occluder in adults

Transcatheter occlusion of patent ductus ateriosus by Rashkind occluder system

ASSA14-14-04 Transcatheter Closure of Patent Ductus Arteriosus in Children with Body Weight ≤ 8 Kg

A Safe Technique for Closure of Patent Ductus Arteriosus in Adult Patients

Transcatheter Closure of Special Patent Ductus Arteriosus

Results of Duct-Occlud or Nit-Occlud Device Occlusion of Patent Ductus Arteriousus

Clinical evaluation of transcatheter closure of PDA with different type of devices

Analysis of the effect of ligation of ductus arteriosus in premature infants

[Factors Influencing the Prognosis of Patent Ductus Arteriosus in Very Low Birth Weight Infants].

Transcatheter closure of patent ductus arteriosus with ≥ 8 mm diameter using th e Amplatzer duct occluder

Transcatheter Closure of Secundum Atrial Septal Defect with Amplatzer Occluder Device

Clinical Application of Minimal Invasive Closure of Atrial Septal Defect Without Cardiopulmonary Bypass

Assessment of the Transcatheter Closure of Patent Ductus Arteriosus in Children

Clinical Study on Application of Amplatzer Duct Occlude-ⅱ to Occlude Patent Ductus Arteriosus

Feasibility and Success of Muscular Ventricular Septal Defect Occluders and Mushroom-Shaped Occluders in Transcatheter Patent Ductus Arteriosus Closure in Low-Weight Children: A Propensity Score-Matched Retrospective Analysis from a Chinese National Regional Health Center

Transcatheter closure of patent ductus arteriosus with the new Amplatzer Duct Occluder Ⅱ

Clinical research of patent ductus arteriosus occlusion

Interventional therapy for patent ductus arteriosus with home-made septal occluders in 93 cases: Evaluation of curative effect and safety

[Transcatheter closure of patent ductus arteriosus with the new Amplatzer Duct OccluderII].